Immune system clues may let some breast cancer patients skip harsh chemo
Disease control
Recruiting now
This study tests a personalized, lighter chemotherapy approach for women with early-stage triple-negative breast cancer. The treatment plan is adjusted based on immune system activity in the tumor and how the tumor shrinks on scans. The goal is to see if many patients can achieve…
Phase: PHASE2 • Sponsor: D'Or Institute for Research and Education • Aim: Disease control
Last updated May 07, 2026 18:43 UTC